ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain

Molecular and Cellular Biology

Volumn 21, Issue 19, 2001, Pages 6470-6483

  Amann, J M ^a   Nip, J ^a   Strom, D K ^a   Lutterbach, B ^a   Harada, H ^a   Lenny, N ^a   Downing, J R ^a   Meyers, S ^a   Hiebert, S W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HYBRID PROTEIN; MUTANT PROTEIN; PROTEIN ETO; PROTEIN MTG16; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE; CELL CYCLE G1 PHASE; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 0034817075     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.19.6470-6483.2001     Document Type: Article

References (45)

1. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO
2. CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells
3. ETO-2: A new member of the ETO-family of nuclear proteins
4. Identification of break-points in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
5. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor
6. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue
7. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
8. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia
9. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
10. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
11. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
12. Three proteins define a class of human histone deacetylases related to yeast Hda1p
13. A core SMRT corepressor complex containing HDAC3 and TBL1: A WD40-repeat protein linked to deafness
14. Histone deacetylase activity is required for full transcriptional repression by mSin3A
15. E2F-I:DP-1 induces p53 and overrides survival factors to trigger apoptosis
16. Multiple regions of ETO cooperate in transcriptional repression
17. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators
18. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor
19. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway
20. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression
21. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1
22. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression
23. Functional domains of the t(8;21) fusion protein, AML-1/ETO
24. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3
25. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia
26. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - A model for overcoming inhibition of proliferation by CBF oncoproteins
27. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
28. The MYND motif is required for repression of basal transcription from the multidrug resistance-I promoter by the t(8;21) fusion protein
29. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
30. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds
31. The PLZF leukemia protein physically and functionally interacts with the ETO leukemia protein suggesting a common link of transcriptional repression in AML
32. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein
33. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
34. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript
35. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
36. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase
37. E2F-1 cooperates with topoisomerase 11 inhibition and DNA damage to selectively augment p53-independent apoptosis
38. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
39. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT)
40. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle
41. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
42. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
43. The histone deacetylase-3 complex contains nuclear receptor corepressors
44. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription and blocks granulocytic differentiation
45. Oligomerization of ETO is obligatory for corepressor interaction